Arrakis Therapeutics

Risk score

57
Large logo of Arrakis Therapeutics

Headquarters

Flag of United States of AmericaUnited States of America

Arrakis holds a straightforward yet potent vision: Expanding the scope of small-molecule medications into uncharted territories of biology, unleashing its potential for therapeutic purposes. Our strategy leverages the existing advanced drug discovery arsenal developed for protein targets, which we are modifying and directing toward the exploration of small-molecule compounds that directly impact RNA.